Description
Recombinant monoclonal antibody to CD226. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma FMU-mCD226.1.
Target
CD226
Target Alias Names
DNAM1, DNAM-1, TLisA1, PTA-1, CD226 antigen, DNAX accessory molecule 1, T lineage specific activation antigen 1, platelet and T cell antigen 1
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression